Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lucid Diagnostics (LUCD) EPS (Basic) (2021 - 2025)

Lucid Diagnostics' EPS (Basic) history spans 5 years, with the latest figure at -$0.1 for Q4 2025.

  • For Q4 2025, EPS (Basic) rose 44.44% year-over-year to -$0.1; the TTM value through Dec 2025 reached -$0.8, up 24.53%, while the annual FY2025 figure was -$0.69, 34.29% up from the prior year.
  • EPS (Basic) reached -$0.1 in Q4 2025 per LUCD's latest filing, roughly flat from -$0.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.08 in Q2 2025 to a low of -$0.52 in Q1 2025.
  • Average EPS (Basic) over 5 years is -$0.31, with a median of -$0.33 recorded in 2023.
  • Peak YoY movement for EPS (Basic): plummeted 34.62% in 2022, then skyrocketed 65.22% in 2025.
  • A 5-year view of EPS (Basic) shows it stood at -$0.32 in 2021, then decreased by 25.0% to -$0.4 in 2022, then soared by 37.5% to -$0.25 in 2023, then rose by 28.0% to -$0.18 in 2024, then soared by 44.44% to -$0.1 in 2025.
  • Per Business Quant, the three most recent readings for LUCD's EPS (Basic) are -$0.1 (Q4 2025), -$0.1 (Q3 2025), and -$0.08 (Q2 2025).